These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2961190)

  • 41. The effects of ipratropium bromide on the histamine inhalation challenge in asthmatic and bronchitic patients.
    Laitinen LA; Viljanen AA; Viljanen BC
    Scand J Respir Dis Suppl; 1979; 103():215-8. PubMed ID: 155301
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
    Brown IG; Chan CS; Kelly CA; Dent AG; Zimmerman PV
    Thorax; 1984 Apr; 39(4):272-6. PubMed ID: 6232724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects.
    Wesseling GJ; Vonk JM; Greve LH; Wouters EF
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):33-8. PubMed ID: 2137435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical study on bronchodilation induced by a metered aerosol of fenoterol in combination with ipratropium bromide.
    Bisetti A; Guerzoni P; Cavalieri C; Moretti M; Marchioni CF
    Respiration; 1986; 50 Suppl 2():160-4. PubMed ID: 2951797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of atrovent on pulmonary ventilation, pulmonary gas exchange and pulmonary hemodynamics in patients with diffuse bronchostenosis].
    Hawryłkiewicz I; Głuskowski J; Zieliński J
    Pneumonol Pol; 1978 Jun; 46(6):451-5. PubMed ID: 151270
    [No Abstract]   [Full Text] [Related]  

  • 46. Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis.
    Spiro SG; Singh CA; Tolfree SE; Partridge MR; Short MD
    Thorax; 1984 Jun; 39(6):432-5. PubMed ID: 6235619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of nebulized ipratropium bromide on lung function in nonallergic bronchial asthma.
    Wegener T; Hedenström H
    Respiration; 1987; 52(1):1-6. PubMed ID: 2958914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease.
    Ashutosh K; Dev G; Steele D
    Chest; 1995 Jan; 107(1):173-8. PubMed ID: 7813271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ipratropium bromide and fenoterol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Br J Clin Pharmacol; 1982 Jul; 14(1):113-5. PubMed ID: 6213250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hemodynamic effects of ipratropium bromide in comparison with atrial stimulation].
    Bergbauer M; Nebel W; Schneider M; Sabin G
    Arzneimittelforschung; 1983; 33(7):977-9. PubMed ID: 6226295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist.
    Chapman KR; Smith DL; Rebuck AS; Leenen FH
    Am Rev Respir Dis; 1985 Oct; 132(4):845-7. PubMed ID: 2864891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Onset of action and maximum effect of bronchodilators administered by a metered dose inhaler. Clinical investigations with fenoterol, hexoprenaline, ipratropium bromide, isoprenaline, orciprenaline, salbutamol and terbutaline (author's transl)].
    Kaik G
    Wien Klin Wochenschr; 1976 Oct; 88(20):674-9. PubMed ID: 136813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bronchodilator action of inhaled fenoterol and ipratropium in normal subjects: a teaching exercise for medical students.
    Taylor RG; Maclagan J; Cook DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):709-13. PubMed ID: 2532922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of fenoterol, ipratropium bromide and their combination--Berodual--on pulmonary ventilation in patients with asthma].
    Chyrek-Borowska S; Rutkowski R; Michalska I; Hofman J
    Pol Tyg Lek; 1989 Jul; 44(27):642-5. PubMed ID: 2534666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nebulized ipritropium bromide and atropine sulfate on tracheal mucous velocity and lung mechanics in anesthetized dogs.
    Sackner MA; Chapman GA; Dougherty RD
    Respiration; 1977; 34(4):181-5. PubMed ID: 143051
    [No Abstract]   [Full Text] [Related]  

  • 57. [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].
    Robinet G; Leroyer C; Andre J; Dewitte JD; Clavier J
    Rev Pneumol Clin; 1989; 45(4):161-3. PubMed ID: 2533994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE; Archer PS; Cayton RM
    Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system (author's transl)].
    Villate Navarro JI; Sobradillo Peña V; Atxotequi Iaraoligoitia V; Salaverri Nalda A; Orive Martínez C
    Med Clin (Barc); 1980 Apr; 74(7):275-9. PubMed ID: 6446008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
    Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
    Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.